Published in Am J Sports Med on September 27, 2001
A review of knowledge in osteochondritis dissecans: 123 years of minimal evolution from König to the ROCK study group. Clin Orthop Relat Res (2013) 1.02
The healing potential of stable juvenile osteochondritis dissecans knee lesions. J Bone Joint Surg Am (2008) 0.97
Accuracy of quantitative magnetic resonance imaging in the detection of ex vivo focal cartilage defects. Ann Rheum Dis (2005) 0.94
Juvenile osteochondritis of femoral condyles: treatment with transchondral drilling. Analysis of 40 cases. J Child Orthop (2009) 0.94
Can fresh osteochondral allografts restore function in juveniles with osteochondritis dissecans of the knee? Clin Orthop Relat Res (2013) 0.91
Surgical management of osteochondritis dissecans of the knee. Curr Rev Musculoskelet Med (2013) 0.89
Drilling juvenile osteochondritis dissecans: retro- or transarticular? Clin Orthop Relat Res (2013) 0.87
MRI-guided percutaneous retrograde drilling of osteochondritis dissecans of the knee. Skeletal Radiol (2011) 0.86
Surgical treatment for osteochondritis dessicans of the knee. Curr Rev Musculoskelet Med (2015) 0.78
Surgical treatment options for osteochondritis dissecans of the knee. Sports Health (2009) 0.77
The Incidence of Surgery in Osteochondritis Dissecans in Children and Adolescents. Orthop J Sports Med (2016) 0.77
Osteochondritis dissecans of the knee. Joints (2014) 0.77
Arthroscopic Bioabsorbable Screw Fixation of Unstable Osteochondritis Dissecans in Adolescents: Clinical Results, Magnetic Resonance Imaging, and Second-Look Arthroscopic Findings. Clin Orthop Surg (2016) 0.75
Internal Fixation of Unstable Osteochondritis Dissecans in the Skeletally Mature Knee with Metal Screws. Cartilage (2015) 0.75
Juvenile osteochondritis dissecans in the lateral femoral condyle requiring osteochondral autograft as a revision procedure: a case report. J Med Case Rep (2016) 0.75
Midterm results of biologic fixation or mosaicplasty and drilling in osteochondritis dissecans. Indian J Orthop (2011) 0.75
OSTEOCHONDRITIS DISSECANS OF THE KNEE: DIAGNOSIS AND TREATMENT. Rev Bras Ortop (2015) 0.75
Osteochondritis Dessicans- Primary Fixation using Bioabsorbable Implants. J Orthop Case Reports (2016) 0.75
Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell (1984) 9.47
Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J (1996) 6.36
A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J (1993) 5.26
Absence of nucleosomes in a fraction of SV40 chromatin between the origin of replication and the region coding for the late leader RNA. Cell (1980) 5.20
Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts. Nature (1988) 5.04
Factors involved in control of tissue-specific expression of albumin gene. Cell (1987) 4.39
Human papillomavirus 1a complete DNA sequence: a novel type of genome organization among papovaviridae. EMBO J (1982) 4.13
E. coli DNA binding protein HU forms nucleosomelike structure with circular double-stranded DNA. Cell (1979) 4.07
Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell (1996) 4.05
Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha). EMBO J (1998) 3.99
The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region. EMBO J (1987) 3.86
Cerebral ischemia. II. The no-reflow phenomenon. Am J Pathol (1968) 3.85
Expression of polyoma early functions in mouse embryonal carcinoma cells depends on sequence rearrangements in the beginning of the late region. Cell (1980) 3.63
Physical and emotional problems of elite female gymnasts. N Engl J Med (1996) 3.57
CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep (2001) 3.55
Characterization of junD: a new member of the jun proto-oncogene family. EMBO J (1989) 3.55
Polyoma DNA sequences involved in control of viral gene expression in murine embryonal carcinoma cells. Nature (1981) 3.47
Wild-type p53 can down-modulate the activity of various promoters. Proc Natl Acad Sci U S A (1991) 3.45
The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. EMBO Rep (2000) 3.30
Specific interaction of cellular factors with the B enhancer of polyoma virus. EMBO J (1985) 3.23
A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron (1995) 3.11
Two different factors bind to the alpha-domain of the polyoma virus enhancer, one of which also interacts with the SV40 and c-fos enhancers. EMBO J (1987) 3.09
Tissue-specific expression is conferred by a sequence from the 5' end of the rat albumin gene. EMBO J (1984) 3.07
Structural and mutational analysis of E2 trans-activating proteins of papillomaviruses reveals three distinct functional domains. EMBO J (1988) 3.01
Several distinct "CCAAT" box binding proteins coexist in eukaryotic cells. Proc Natl Acad Sci U S A (1988) 3.01
Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg (1999) 2.99
A liver-specific factor essential for albumin transcription differs between differentiated and dedifferentiated rat hepatoma cells. Genes Dev (1988) 2.97
Chromatin-like structures in polyoma virus and simian virus 10 lytic cycle. J Virol (1975) 2.82
A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods (1998) 2.79
The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis. EMBO J (1996) 2.71
Comparative analysis of the human type 1a and bovine type 1 papillomavirus genomes. J Virol (1983) 2.69
Assembly of transfected DNA into chromatin: structural changes in the origin-promoter-enhancer region upon replication. EMBO J (1984) 2.69
Cerebral ischemia. III. Vascular changes. Am J Pathol (1968) 2.67
Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. EMBO J (2000) 2.66
Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells. Nature (1987) 2.65
Alignment in total knee arthroplasty. A comparison of computer-assisted surgery with the conventional technique. J Bone Joint Surg Br (2004) 2.63
RB and hbrm cooperate to repress the activation functions of E2F1. Proc Natl Acad Sci U S A (1997) 2.53
Determinants of rat albumin promoter tissue specificity analyzed by an improved transient expression system. Mol Cell Biol (1987) 2.52
Fine structure of the origin-proximal DNAase I-hypersensitive region in wild-type and EC mutant polyoma. Cell (1981) 2.52
Components of the human SWI/SNF complex are enriched in active chromatin and are associated with the nuclear matrix. J Cell Biol (1997) 2.50
The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes. J Virol (1989) 2.50
Analysis of the distribution of binding sites for a tissue-specific transcription factor in the vertebrate genome. J Mol Biol (1997) 2.47
Fine structure of the cottontail rabbit papillomavirus mRNAs expressed in the transplantable VX2 carcinoma. J Virol (1985) 2.40
Genomic structure of the cottontail rabbit (Shope) papillomavirus. Proc Natl Acad Sci U S A (1985) 2.40
A simple freeze-fracture replication method for electron microscopy. J Cell Biol (1966) 2.40
Increased incidence of matrix metalloproteinases in urine of cancer patients. Cancer Res (1998) 2.33
Differentiating between septic arthritis and transient synovitis of the hip in children: an evidence-based clinical prediction algorithm. J Bone Joint Surg Am (1999) 2.32
Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer. Urology (1999) 2.30
Activation of the polyomavirus enhancer by a murine activator protein 1 (AP1) homolog and two contiguous proteins. Proc Natl Acad Sci U S A (1988) 2.24
The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex. Genes Dev (1991) 2.24
A dimer of BPV-1 E2 containing a protease resistant core interacts with its DNA target. EMBO J (1988) 2.22
Characterization of a transcriptional promoter of human papillomavirus 18 and modulation of its expression by simian virus 40 and adenovirus early antigens. J Virol (1987) 2.21
vHNF1 is a homeoprotein that activates transcription and forms heterodimers with HNF1. EMBO J (1991) 2.19
The mammalian Jun proteins: redundancy and specificity. Oncogene (2001) 2.13
Regulation of eukaryotic gene expression by transactivating proteins and cis acting DNA elements. Biol Cell (1984) 2.13
Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes (2001) 2.08
Scapulothoracic motion in normal shoulders and shoulders with glenohumeral instability and impingement syndrome. A study using Moiré topographic analysis. Clin Orthop Relat Res (1992) 2.07
A single mutational modification of a tryptophan-specific transfer RNA permits aminoacylation by glutamine and translation of the codon UAG. J Mol Biol (1974) 2.05
A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma. Ophthalmology (1998) 2.03
[Thermosensitive mutations of systems activating valine in E. coli]. Bull Soc Chim Biol (Paris) (1965) 2.02
Induction of apoptosis by the transcription factor c-Jun. EMBO J (1997) 2.02
HNF1, a homeoprotein member of the hepatic transcription regulatory network. Bioessays (1992) 2.01
Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell (1994) 2.00
JunD protects cells from p53-dependent senescence and apoptosis. Mol Cell (2000) 1.99
A human protein with homology to Saccharomyces cerevisiae SNF5 interacts with the potential helicase hbrm. Nucleic Acids Res (1995) 1.92
Reticulocyte hemoglobin content to diagnose iron deficiency in children. JAMA (1999) 1.90
Structure of transfer RNA. Evidence for interaction between two non-adjacent nucleotide residues in tRNA from Escherichia coli. Nature (1969) 1.90
Reflex sympathetic dystrophy in children. Clinical characteristics and follow-up of seventy patients. J Bone Joint Surg Am (1992) 1.89
Cerebral ischemia. I. An improved experimental method for study; cardiovascular effects and demonstration of an early vascular lesion in the rabbit. J Neurosurg (1968) 1.88
Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice. J Clin Invest (1998) 1.86
Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J (1997) 1.85
Interplay of viral and cellular proteins along the long control region of human papillomavirus type 18. J Virol (1988) 1.85
Patterns of flexibility, laxity, and strength in normal shoulders and shoulders with instability and impingement. Am J Sports Med (1990) 1.83
Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology (2000) 1.82
Transformation by ras modifies AP1 composition and activity. Oncogene (1997) 1.80
When the SWI/SNF complex remodels...the cell cycle. Oncogene (2001) 1.79
Enhancing elements for activation of eukaryotic promoters. Nature (1982) 1.74
A distal dimerization domain is essential for DNA-binding by the atypical HNF1 homeodomain. Nucleic Acids Res (1990) 1.73
Nucleotide sequence of E. coli B tRNA1-Val. Nature (1969) 1.71
Bankart repair for anterior instability of the shoulder. Long-term outcome. J Bone Joint Surg Am (1997) 1.70
Stress response in infants undergoing cardiac surgery: a randomized study of fentanyl bolus, fentanyl infusion, and fentanyl-midazolam infusion. Anesth Analg (2001) 1.70
Characterization of mammary tumors from Brg1 heterozygous mice. Oncogene (2007) 1.70
Responses to acetylcholine of ganglion cells in an isolated mammalian retina. J Neurophysiol (1976) 1.69
ATP-dependent chromatin remodelling: SWI/SNF and Co. are on the job. J Mol Biol (1999) 1.69
Fine structure of the regulatory region of simian virus 40 minichromosomes revealed by DNAase I digestion. J Mol Biol (1982) 1.68
Constitutive synthesis of activator protein 1 transcription factor after viral transformation of mouse fibroblasts. Proc Natl Acad Sci U S A (1988) 1.67
Molecular cloning, refined physical map and heterogeneity of methylation sites of papilloma virus type 1a DNA. Eur J Biochem (1980) 1.64
Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol (1996) 1.64
In vitro retina as an experimental model of the central nervous system. J Neurochem (1981) 1.63
Cooperative activation of transcription by bovine papillomavirus type 1 E2 can occur over a large distance. Mol Cell Biol (1990) 1.63
Hepatic nuclear factor 1 (HNF1) shows a wider distribution than products of its known target genes in developing mouse. Development (1991) 1.62
Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium:YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplasty. Ophthalmology (1998) 1.61
Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes. J Virol (1992) 1.59
ras transformation is associated with decreased expression of the brm/SNF2alpha ATPase from the mammalian SWI-SNF complex. EMBO J (1998) 1.59
Both Jun and Fos contribute to transcription activation by the heterodimer. Oncogene (1990) 1.59
Expression of the vHNF1/HNF1beta homeoprotein gene during mouse organogenesis. Mech Dev (1999) 1.58
Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes. J Virol (1997) 1.56
Transcription factor-dependent regulation of CBP and P/CAF histone acetyltransferase activity. EMBO J (2001) 1.55
Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype. Infect Immun (1999) 1.54
DNA replication origin of polyoma virus: early proximal boundary. J Virol (1983) 1.54